StockData
GSK plc logo

GSK plc (GSK) stock

GSKNYSEPharmaceutical PreparationsAlso trades as GLAXF
Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30
$49.24−1.17 (-2.32%)

Close on Nov 17, 2026Market cap $106.25BP/E 13.4Yield –

GSK cash

Cash and short-term investments held at the end of each period.

GSK's cash was £3.40B at Dec 31, 2025. For fiscal 2025 it was £3.40B, down 12.2% from the year before. Over ten years it grew -5.3% a year on average. The highest annual figure on record is £6.29B in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025£3.40B-12.2%
FY2024Dec 31, 2024£3.87B+31.8%
FY2023Dec 31, 2023£2.94B-21.1%
FY2022Dec 31, 2022£3.72B-12.9%
FY2021Dec 31, 2021£4.27B-32.1%
FY2020Dec 31, 2020£6.29B+33.7%
FY2019Dec 31, 2019£4.71B+21.5%
FY2018Dec 31, 2018£3.87B+1.1%
FY2017Dec 31, 2017£3.83B-21.7%
FY2016Dec 31, 2016£4.90B-16.0%
FY2015Dec 31, 2015£5.83B–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025£3.40B-20.5%
Q4 FY2024Dec 31, 2024£3.87B-38.5%
Q4 FY2023Dec 31, 2023£2.94B-37.6%
Q4 FY2022Dec 31, 2022£3.72B-3.9%
Q4 FY2021Dec 31, 2021£4.27B+11.5%
Q4 FY2020Dec 31, 2020£6.29B+28.5%
Q4 FY2019Dec 31, 2019£4.71B-19.3%
Q4 FY2018Dec 31, 2018£3.87B–
Q4 FY2017Dec 31, 2017£3.83B–
Q4 FY2016Dec 31, 2016£4.90B–
Q4 FY2015Dec 31, 2015£5.83B–

More GSK figures

See a number that looks wrong?